CLOXACILLIN SODIUM FOR INJECTION 2 G — DIN 01912410
CLOXACILLIN SODIUM : 2 G · TEVA CANADA LIMITED · POWDER FOR SOLUTION · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is CLOXACILLIN SODIUM FOR INJECTION?
CLOXACILLIN SODIUM FOR INJECTION 2 G contains CLOXACILLIN SODIUM : 2 G. It is listed in the Health Canada Drug Product Database under DIN 01912410, held by TEVA CANADA LIMITED, supplied as POWDER FOR SOLUTION for INTRAMUSCULAR ; INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 01-Dec-2017. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
What is CLOXACILLIN SODIUM FOR INJECTION used for?
Treatment of beta-hemolytic streptococcal, pneumococcal, and staphylococcal infections (including beta-lactamase producing strains). Not effective against methicillin-resistant strains.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Cloxacillin cost around the world?
Cloxacillin is listed on 4 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Greece publishes a producer price (ex-factory); Iceland publishes a max wholesale; Saudi Arabia publishes a public. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| South Africa | single exit price | 6 | 10 | ZAR███.██ |
| Saudi Arabia | public | 5 | 5 | SAR███.██ |
| Iceland | max wholesale | 4 | 4 | ISK███.██ |
| Greece | producer price (ex-factory) | 1 | 1 | EUR███.██ |
20 pack listings across 16 brand entries and 4 price bases, refreshed 03 Sep 2026. Ranges span every Cloxacillin pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Cloxacillin in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
12 holders have a Canadian DIN containing Cloxacillin, across 36 DINs, of which 9 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| STERIMAX INC | 4 | 4 | CLOXACILLIN FOR INJECTION | Sourceable in Canada |
| TEVA CANADA LIMITED | 6 | 3 | CLOXACILLIN SODIUM FOR INJECTION, TEVA-CLOXACILLIN | Sourceable in Canada |
| JAMP PHARMA CORPORATION | 2 | 2 | JAMP CLOXACILLIN | Sourceable in Canada |
| AYERST LABORATORIES | 6 | 0 | ORBENIN CAP 250MG, ORBENIN CAP 500MG, ORBENIN INJ 2000MG, ORBENIN INJ 250MG, ORBENIN INJ 500MG, +1 more | No marketed DIN |
| APOTEX INC | 3 | 0 | APO CLOXI CAP 250MG, APO CLOXI CAP 500MG, APO CLOXI FOR ORAL SOLN 125MG/5ML | No marketed DIN |
| BRISTOL LABS DIVISION OF BRISTOL-MYERS SQUIBB | 3 | 0 | TEGOPEN INJ 2000MG/VIAL, TEGOPEN INJ 250MG/VIAL, TEGOPEN INJ 500MG/VIAL | No marketed DIN |
| NU-PHARM INC | 3 | 0 | NU-CLOXI CAPSULES 250MG, NU-CLOXI CAPSULES 500MG, NU-CLOXI SOLUTION 125MG/5ML | No marketed DIN |
| LABORATOIRE RIVA INC. | 2 | 0 | RIVA-CLOXACILLIN 250 MG CAPSULES, RIVA-CLOXACILLIN 500 MG CAPSULES | No marketed DIN |
| PRO DOC LIMITEE | 2 | 0 | CLOXACILLIN, CLOXACILLIN-250 CAP | No marketed DIN |
| TARO PHARMACEUTICALS INC | 2 | 0 | TARO-CLOXACILLIN CAP 250MG, TARO-CLOXACILLIN CAP 500MG | No marketed DIN |
| WYETH-AYERST CANADA INC. | 2 | 0 | ORBENIN 500 CAP 500MG, ORBENIN PWS 125MG/5ML | No marketed DIN |
| NOVOPHARM LIMITED | 1 | 0 | CLOXACILLIN SODIUM STERILE INJ 250MG/VIAL | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 2 G |
|---|---|
| Dosage form | POWDER FOR SOLUTION |
| Route | INTRAMUSCULAR ; INTRAVENOUS |
| Pack configuration (monograph) | Vials containing 500 mg, 1000 mg, or 2000 mg of cloxacillin base as the sodium salt. |
| Storage | Store dry powder at room temperature (up to 25°C). Reconstituted: immediate use recommended; stable 24h at room temp or 48h refrigerated. |
| Shipping class | Cold chain — validated shipper with temperature monitoring |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Cloxacillin |
|---|---|
| ATC code | J01CF02 |
| AHFS class | 08:12.16.12 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 01912410 |
|---|---|
| DIN (unpadded, as printed on some documents) | 1912410 |
| Brand name | CLOXACILLIN SODIUM FOR INJECTION |
| Generic / active ingredient | CLOXACILLIN SODIUM : 2 G |
| Market authorization holder | TEVA CANADA LIMITED |
| Health Canada schedule | Prescription |
| ATC code | J01CF02 |
| ATC anatomical main group | J — Anti-infectives for systemic use |
| ATC therapeutic subgroup | J01CF |
| Current status | CANCELLED POST MARKET |
| Status date | 01-Dec-2017 |
| Original market date | 1992-12-31 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Adults: 250-500 mg every 6h (max 6g/day). Children <20kg: 25-50 mg/kg/day in 4 doses. Administer by IM or IV injection (2-4 mins) or IV infusion (30-40 mins).
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
A history of allergic reactions to penicillin or cephalosporins.
Warnings and precautions
Serious/fatal hypersensitivity (anaphylactoid) reactions. Risk of superinfections (e.g., Candidiasis). CNS effects (seizures) possible in renal failure or inflamed meninges.
Is Cloxacillin in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by STERIMAX INC, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
9 of 36 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| CLOXACILLIN FOR INJECTION | 500 MG | POWDER FOR SOLUTION | STERIMAX INC | MARKETED | 02367408 |
| CLOXACILLIN FOR INJECTION | 1 G | POWDER FOR SOLUTION | STERIMAX INC | MARKETED | 02367416 |
| CLOXACILLIN FOR INJECTION | 2 G | POWDER FOR SOLUTION | STERIMAX INC | MARKETED | 02367424 |
| CLOXACILLIN FOR INJECTION | 10 G | POWDER FOR SOLUTION | STERIMAX INC | MARKETED | 02400081 |
| JAMP CLOXACILLIN | 500 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | 02510758 |
| JAMP CLOXACILLIN | 250 MG | CAPSULE | JAMP PHARMA CORPORATION | MARKETED | 02510731 |
| TEVA-CLOXACILLIN | 125 MG / 5 ML | GRANULES FOR SOLUTION | TEVA CANADA LIMITED | MARKETED | 00337757 |
| TEVA-CLOXACILLIN | 500 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED | 00337773 |
| TEVA-CLOXACILLIN | 250 MG | CAPSULE | TEVA CANADA LIMITED | MARKETED | 00337765 |
| APO CLOXI CAP 250MG | 250 MG | CAPSULE | APOTEX INC | CANCELLED POST MARKET | 00618292 |
2 · Same class — other molecules in ATC J01CF
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Cloxacillin | APO CLOXI CAP 250MG · APO CLOXI CAP 500MG · APO CLOXI FOR ORAL SOLN 125MG/5ML · CLOXACILLIN · +24 more | 36 | 9 | Yes |
| Flucloxacillin | FLUCLOX 250 · FLUCLOX 250 CAP 250MG · FLUCLOX 500 CAP 500MG · FLUCLOX-125 PWS 125MG/5ML · +1 more | 5 | 0 | Not in Canada |
| Beta-Lactamase Resistant Penicillins | UNIPEN INJECTION PWS 500MG/VIAL | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC J01C
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| J01CA | Amoxicillin · Ampicillin · Ampicillin, Combinations · Bacampicillin · Piperacillin · +3 more | 201 | 47 |
| J01CR | Amoxicillin And Beta-Lactamase Inhibitor · Piperacillin And Beta-Lactamase Inhibitor · Ticarcillin And Beta-Lactamase Inhibitor | 113 | 44 |
| J01CE | Benzathine Benzylpenicillin · Benzathine Phenoxymethylpenicillin · Benzylpenicillin · Combinations · Phenoxymethylpenicillin · +1 more | 69 | 4 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is CLOXACILLIN SODIUM FOR INJECTION called?
The same molecule, Cloxacillin, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Cloxin | Latin | South Africa |
| Sandoz Cloxacillin | Latin | South Africa |
| Orbenin L.A. | Latin | Iceland |
| Orbenin vet. | Latin | Iceland |
| Wedeclox Mastitis | Latin | Iceland |
| WEDECLOX MASTITIS INJECTOR | Latin | Iceland |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.